Results 121 to 130 of about 132,650 (237)

Multichannel intraluminal impedance (MII) in the evaluation of patients with persistent GERD symptoms despite proton pump inhibitors (PPI): A multicenter study [PDF]

, 2003
Steven S. Shay, Daniel Sifrim, Radu Țuțuian, Xin Zhang, Marcelo F. Vela, Donald O. Castell   +5 more
openalex   +1 more source

Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study. [PDF]

Cancer Med
Cortes-Mejia N, Wong R, Eltzschig HK, Moreno-Lopez SM, Bejarano-Ramirez D, Huang H, Cata JP.   +6 more
europepmc   +1 more source

Disease severity and proton pump inhibitor use impacts strongest on faecal microbiome composition in cirrhosis

, 2020
Vanessa Stadlbauer, Irina Komarova, Ingeborg Klymiuk, Marija Durdević, Alexander J. Reisinger, Andreas Blesl, Florian Rainer, Angela Horvath   +7 more
openalex   +1 more source

The Acid Test: Is Proton Pump Inhibitor Therapy an Independent Risk Factor for Clostridium difficile-Associated Disease? [PDF]

, 2007
Christina M. Surawicz
openalex   +1 more source

Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. [PDF]

Pediatr Allergy Immunol
Gautam R, Lal M, Carroll MC, Mrozek Z, Trachsel T, Beers J, Ruffner MA.   +6 more
europepmc   +1 more source

CV3 THE IMPACT OF PROTON PUMP INHIBITORS ON CARDIOVASCULARRELATED EVENT COSTS IN PATIENTS INITIATING CLOPIDOGREL

, 2009
RE Aubert, EJ Stanek, J. Yao, FW Frueh, J. Russell Teagarden, RS Epstein   +5 more
openalex   +1 more source

Abstract No. 627 Proton pump inhibitors are associated with increased risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation [PDF]

, 2018
Deborah Lewis, Paul V. Suhocki, Matthew J. Hall, T.P. Smith, Cho Hee Kim, James Ronald   +5 more
openalex   +1 more source

Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study. [PDF]

Basic Clin Pharmacol Toxicol
Soliman AI, Wactawski-Wende J, Millen AE, Hovey KM, LaMonte MJ.   +4 more
europepmc   +1 more source

The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis. [PDF]

BMC Gastroenterol
Atasoy H, Levent A.
europepmc   +1 more source

Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment. [PDF]

Sci Rep
Takada S, Takahashi K, Uozumi R, Mukohara T, Hayashida T, Iwabe M, Iihara H, Kusuhara-Mamishin K, Tahatsu K, Kitagawa Y, Tsuchiya M, Kitahora M, Umehara K, Nagayama A, Kosaka S, Asano-Niwa Y, Watanabe K, Seki T, Ohnuki K, Futamura M, Kawazoe H, Nakamura T.   +21 more
europepmc   +1 more source